Genomic and tumor testing at SABCS 2026
Dec 8–11, 2026 San Antonio, TX ~11k attendees Website
22 organizations at SABCS 2026 present work in genomic and tumor testing. 22 of them have their own page in this guide. As of Sep 27, 2026.
Showing 1–20 of 22 organizations
| Organization | SABCS 2026 Attendance |
|---|---|
Agendia Irvine, CA | |
Genomic tests for early-stage breast cancer, including MammaPrint and BluePrint, that help clinicians weigh recurrence risk and choose treatment. | Booth Exhibiting at Booth 1242 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Artera Los Altos, CA | |
Multimodal AI tests that read digitized pathology slides alongside clinical data to judge how aggressive a cancer is and who benefits from therapy. | Booth Exhibiting at Booth 1544 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
ARTIDIS Basel, Switzerland | |
Nanotechnology-based analysis of biopsy tissue, paired with a data platform, to help guide treatment of solid tumors. | Booth Exhibiting at Booth 849 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Ataraxis New York, NY | |
AI tests that read routine pathology slides and patient data to estimate outcomes and guide treatment in every subtype of invasive breast cancer. | Booth Exhibiting at Booth 1524 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Bio-Techne Diagnostics Austin, TX | |
Asuragen molecular diagnostic kits and software, including the QuantideX line for cancer monitoring and diagnosis, run on widely installed lab instruments. | Booth Exhibiting at Booth 1430 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
BostonGene Waltham, MA | |
AI platform with its own CLIA lab that profiles tumors' molecular and immune features to guide therapy choices and help drug developers select trial patients. | Booth Exhibiting at Booth 1248 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Caris Life Sciences Irving, TX | |
Molecular profiling company whose tissue and blood tests, backed by AI, map a tumor's DNA, RNA and proteins to guide cancer treatment. | Booth Exhibiting at Booth 1215 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Delphi Diagnostics Houston, TX | |
Commercializing a test licensed from MD Anderson that scores endocrine activity in HR+/HER2- stage II–III tumors to guide therapy. | Booth Exhibiting at Booth 1528 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Exact Sciences Madison, WI | |
Cancer screening and diagnostics company, now part of Abbott, known for the Oncotype DX breast recurrence test and the Cologuard screening test. | Booth Exhibiting at Booth 843 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Foundation Medicine Boston, MA | |
Genomic profiling tests on tumor tissue and blood that help physicians choose cancer treatments and support drug research. | Booth Exhibiting at Booth 1346 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Guardant Health Palo Alto, CA | |
Cancer testing company: blood tests for screening and recurrence monitoring, tissue and blood profiling to pick treatment, and data services for drug developers. | Booth Exhibiting at Booth 814 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Hologic Marlborough, MA | |
Women's health technology company whose Breast Cancer Index test helps decide whether early HR+ breast cancer warrants hormone therapy beyond five years. | Booth Exhibiting at Booth 915 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Inocras San Diego, CA | |
Whole-genome sequencing company using its own analytics to turn genome data into clinical and research insights for precision health. | Booth Exhibiting at Booth 247 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
MultiplexDX Bratislava, Slovakia | |
Slovak developer of tumor tests that combine multiplex RNA FISH and RNA sequencing to measure several cancer markers at single-cell resolution. | Booth Exhibiting at Booth 1350 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Myriad Oncology Salt Lake City, UT | |
Hereditary cancer risk and tumor genomic tests from Myriad Genetics, used from risk assessment and screening through treatment and survivorship. | Booth Exhibiting at Booth 215 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Natera San Carlos, CA | |
Cell-free DNA blood tests for cancer: tumor-informed MRD monitoring with Signatera, treatment response, genomic profiling and hereditary risk. | Booth Exhibiting at Booth 909 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
NeoGenomics Fort Myers, FL | |
Cancer diagnostics company running CLIA-certified labs that offer a broad oncology testing menu to oncologists, pathologists, hospitals and drug developers. | Booth Exhibiting at Booth 242 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
PreludeDx Laguna Hills, CA | |
Genomic tests that help decide on surgery and radiation: DCISionRT in DCIS and AidaBreast in early invasive breast cancer. | Booth Exhibiting at Booth 1208 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Reveal Genomics Barcelona, Spain | |
Barcelona company behind HER2DX, a genomic test that estimates recurrence risk and treatment response in early HER2-positive breast cancer. | Booth Exhibiting at Booth 1252 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Tempus Chicago, IL | |
AI-driven precision medicine company offering genomic testing and data tools to physicians and helping drug developers with discovery and trials. | Booth Exhibiting at Booth 1332 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Instantly find 20 buyers in genomic and tumor testing
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Browse SABCS 2026 by
Organization type
Focus
- Patient and family support 26
- Genomic and tumor testing 22
- Hormone receptor-positive breast cancer 17
- Clinical trials and research 16
- HER2-positive breast cancer 10
- Liquid biopsy and MRD 10
- AI and data 9
- Screening and early detection 9
- Side effects and supportive care 8
- Breast surgery and biopsy 8
- Metastatic breast cancer 5
- Triple-negative breast cancer 4
- Hereditary risk and genetic testing 4
Exhibit hall
Everyone
Not affiliated with the San Antonio Breast Cancer Symposium, UT Health San Antonio or the American Association for Cancer Research. Organization details are derived from SABCS’s published exhibitor list. Submit a correction